You can view the latest news of the Company.
 
Select Another Company
 
Market Cap. (Rs.) 104496.69 Cr. P/BV 5.02 Book Value (Rs.) 455.22
52 Week High/Low (Rs.) 2494/1837 FV/ML 2/1 P/E(X) 19.59
Bookclosure 25/07/2025 EPS (Rs.) 116.64 Div Yield (%) 0.79
Date and TimeHeadlines
19/05/2026 11:46 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
19/05/2026 11:43 Lupin - Press Release
18/05/2026 21:12 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
18/05/2026 21:08 Lupin - Press Release
15/05/2026 11:44 Lupin launches advanced Neuro-Rehabilitation Centre ‘Atharv A...
15/05/2026 11:17 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
15/05/2026 11:12 Lupin - Press Release
14/05/2026 17:12 Lupin - Announcement under Regulation 30 (LODR)-Earnings Call Trans...
14/05/2026 17:09 Lupin - Analysts/Institutional Investor Meet/Con. Call Updates
13/05/2026 18:29 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
13/05/2026 18:26 Lupin - Press Release
13/05/2026 18:25 Lupin Ltd gets USFDA approval for Famotidine Injection
09/05/2026 13:32 Lupin - Copy of Newspaper Publication
08/05/2026 21:23 Lupin - Announcement under Regulation 30 (LODR)-Analyst / Investor ...
08/05/2026 21:22 Lupin - Analysts/Institutional Investor Meet/Con. Call Updates
07/05/2026 21:44 Lupin - Announcement under Regulation 30 (LODR)-Investor Presentation
07/05/2026 21:42 Lupin - Investor Presentation
07/05/2026 21:33 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
07/05/2026 21:30 Lupin - Press Release
07/05/2026 21:25 Lupin - Announcement under Regulation 30 (LODR)-Appointment of Stat...
12